Topics

TOPICS

ANEMIA

FDA Panel Votes on Daprodustat for Anemia of Chronic Kidney Disease

Ticagrelor Does Not Meet Endpoint Compared With Placebo in Treatment of Pediatric Sickle Cell Disease

BLEEDING DISORDERS

First Gene Therapy for Hemophilia B Gets FDA Approval

Combination Regimen Highly Effective for Acquired Hemophilia A

GENERAL HEMATOLOGY

Mindfulness Program Reduces Burnout, Compassion Fatigue in Nurses

Study Reveals Pregnancy-Related Discrimination in Oncology

LEUKEMIA

FLT3-ITD Measurable Residual Disease Is a Clinically Relevant Biomarker for Disease Risk Assessment in AML

Filgrastim Biosimilar Releuko Now Available

LYMPHOMA

WBRT May Not Yield Optimal Outcomes in Primary CNS Lymphoma

Ibrutinib Improves Survival vs Chemotherapy in CNS-Involved MCL

MYELODYSPLASTIC SYNDROMES

Ongoing Study Evaluates Diagnosis of Myelodysplastic Syndrome With Peripheral Blood Samples

Clinical Outcomes Similar With 5- or 7-Day Azacitidine in Lower-Risk Myelodysplastic Syndrome

MYELOMA

Loss of 2q37 Linked to Immunomodulatory Drug Resistance in Multiple Myeloma

Isatuximab Plus RVd Dubbed New Standard Care in Newly Diagnosed Multiple Myeloma

SIDE EFFECT MANAGEMENT

Disruption to Gut Microbiome Predictive of Acute GVHD Severity, Outcomes

ONS Releases Guidelines on the Management of Cancer Treatment–Related Hot Flashes

THALASSEMIAS

Reduced Exercise Capacity Associated With Cardiac Iron Overload in Beta-Thalassemia Major

High Prevalence of Metabolic Bone Disease Seen in Children With Transfusion-Dependent Thalassemia

THROMBOTIC DISORDERS

Study of Mirasol®-Based Pathogen Reduction in Platelets Fails to Meet Primary Endpoint

Risks of Intraventricular Hemorrhage and Death May Be Higher in Preterm Infants

Next post in Leukemia

Filgrastim Biosimilar Releuko Now Available